Available Until 6/8/2028

Summit on Advanced Therapeutics - Pharmacy, Laboratory, and Clinical Collaboration: Advanced Therapeutics from Bench to Bedside

There is no CE associated with this activity
Release Date:  June 08, 2025
Expiration Date: June 08, 2028
Activity Fee: Free for members
This session was part of ASHP’s Summit on Advanced Therapeutics at Pharmacy Futures 2025. There is no CE associated with this activity.

Activity Overview 

This session will provide participants with insights into best practices for optimizing data sharing and coordination within healthcare systems. Additionally, the webinar will review an in-depth look at the operational workflows of cell laboratories and pharmacy departments in managing these advanced therapeutics. 

ACPE Provider with Commendation logo

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity is intended to meet the professional development needs of Certified Pharmacy Executive Leaders.  

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.